Cargando…

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center

(1) Background: There is growing interest in the assessment of muscular mass in inflammatory bowel disease (IBD) as sarcopenia is associated with important outcomes. The aim of the study was to evaluate the percentage of sarcopenia in IBD patients, characterizing methods for assessment and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pizzoferrato, Marco, de Sire, Roberto, Ingravalle, Fabio, Mentella, Maria Chiara, Petito, Valentina, Martone, Anna Maria, Landi, Francesco, Miggiano, Giacinto Abele Donato, Mele, Maria Cristina, Lopetuso, Loris Riccardo, Schiavoni, Elisa, Napolitano, Daniele, Turchini, Laura, Poscia, Andrea, Nicolotti, Nicola, Papa, Alfredo, Armuzzi, Alessandro, Scaldaferri, Franco, Gasbarrini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835412/ https://www.ncbi.nlm.nih.gov/pubmed/31554166 http://dx.doi.org/10.3390/nu11102281

Ejemplares similares

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide
por: Scaldaferri, F., et al.
Publicado: (2017)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

The Role of Nutrition in the COVID-19 Pandemic
por: Mentella, Maria Chiara, et al.
Publicado: (2021)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

Cancer and Mediterranean Diet: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
por: Rinninella, Emanuele, et al.
Publicado: (2019)

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
por: Scaldaferri, Franco, et al.
Publicado: (2023)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis
por: Di Vincenzo, Federica, et al.
Publicado: (2022)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis
por: Lopetuso, Loris R, et al.
Publicado: (2016)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients
por: Poscia, A., et al.
Publicado: (2017)

Gut–Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis
por: de Sire, Alessandro, et al.
Publicado: (2020)

When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach
por: Tursi, Antonio, et al.
Publicado: (2022)

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase
por: Papa, Alfredo, et al.
Publicado: (2020)

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2018)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
por: Lopetuso, Loris R, et al.
Publicado: (2012)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases
por: Rinninella, Emanuele, et al.
Publicado: (2019)

Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
por: Graziani, Cristina, et al.
Publicado: (2022)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Microbiota Composition in Diverticular Disease: Implications for Therapy
por: Tursi, Antonio, et al.
Publicado: (2022)

Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure
por: Nardone, Olga Maria, et al.
Publicado: (2021)

Human herpesvirus 8-associated colonic Kaposi’s sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature
por: Papa, Valerio, et al.
Publicado: (2020)

Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis
por: Raoul, Pauline, et al.
Publicado: (2022)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis
por: Petito, Valentina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vuq9llcaeph37dg6v6goq6cf3s